4
Participants
Start Date
June 15, 2018
Primary Completion Date
September 18, 2019
Study Completion Date
September 18, 2019
Botox
THE PROTOCOL DESCRIPTION ATTEMPTED TO OUTLINE A CONTINGINECY PLAN- MOVING TO ONE OF TWO METHODOLOGOIES DPENDING ON PRELIMINARY FINDINGS. UNFORTUNATLEY, OVER 2 YEARS RECRUITMENT WAS GROSSLY INADEQUATE PREVENTING ANY TYPE OF EVEN CURSURY PRELIMINARY DATA ANALYSIS AND FORCING THE EARLY TERMINATION OF THIS STUDY. MICHAEL W. O'DELL, MD
NewYork Presbyterian Hospital - Weill Cornell Medicine, New York
Collaborators (1)
Allergan
INDUSTRY
Weill Medical College of Cornell University
OTHER